Thursday, June 23, 2016
- 12:00pm-1:30pm
-
The role of proprioceptive deficits as a mechanism of gait impairments in postural instability and gait disorder Parkinson’s disease subtype
Other · Exhibit Hall located in Hall B, Level 2
- 12:00pm-1:30pm
-
The sense of agency is altered in cervical dystonia
Dystonia · Exhibit Hall located in Hall B, Level 2
- 12:00pm-1:30pm
-
The serum response factor SRF protect dopamine (DA) neurons in Parkinson’s disease partially by mediate autophagy through a beclin 1-dependent pathway
Other · Exhibit Hall located in Hall B, Level 2
- 12:00pm-1:30pm
-
The systemic synuclein sampling study (S4)
Clinical trials and therapy in movement disorders · Exhibit Hall located in Hall B, Level 2
- 12:00pm-1:30pm
-
The unfolded protein response pathway as a possible therapeutic target for the synucleinopathies
Neuropharmacology · Exhibit Hall located in Hall B, Level 2
- 12:00pm-1:30pm
-
The writer’s cramp and its connections with sensory deficits
Dystonia · Exhibit Hall located in Hall B, Level 2
- 12:00pm-1:30pm
-
Therapeutic effect of onabotulinumtoxinA (BoNT/A) in hemifacial spasm and trigeminal neuralgia post Ramsay Hunt Syndrome type II
Other · Exhibit Hall located in Hall B, Level 2
- 12:00pm-1:30pm
-
Therapeutic potential of compounds preferring specific GABAA receptor subunits for the treatment of dystonia?
Dystonia · Exhibit Hall located in Hall B, Level 2
- 12:00pm-1:30pm
-
Therapeutic protocol for Parkinson’s patient with freezing based on action observation plus sonification: Preliminary results
Clinical trials and therapy in movement disorders · Exhibit Hall located in Hall B, Level 2
- 12:00pm-1:30pm
-
Therapeutic yoga improves balance and balance confidence in Parkinson’s disease
Parkinson's disease: Clinical trials, pharmacology and treatment · Exhibit Hall located in Hall B, Level 2